ISIN | LU1600334798 |
---|---|
Valor Number | 36465638 |
Bloomberg Global ID | UIMF GR |
Fund Name | UBS (Lux) Fund Solutions – UBS Core MSCI Europe UCITS ETF hEUR acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the MSCI Europe Index (Net Return) (this sub-fund's "Index"). |
Peculiarities |
Current Price * | 16.95 EUR | 01.07.2025 |
---|---|---|
Previous Price * | 16.98 EUR | 30.06.2025 |
52 Week High * | 17.30 EUR | 06.06.2025 |
52 Week Low * | 14.59 EUR | 09.04.2025 |
NAV * | 16.95 EUR | 01.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 613,648,058 | |
Unit/Share Assets *** | 72,283,628 | |
Trading Information SIX |
YTD Performance | +9.39% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
---|---|---|
YTD Performance (in CHF) | +8.66% |
31.12.2024 - 01.07.2025
31.12.2024 01.07.2025 |
1 month | -0.83% |
02.06.2025 - 01.07.2025
02.06.2025 01.07.2025 |
3 months | +1.94% |
01.04.2025 - 01.07.2025
01.04.2025 01.07.2025 |
6 months | +8.66% |
02.01.2025 - 01.07.2025
02.01.2025 01.07.2025 |
1 year | +7.50% |
01.07.2024 - 01.07.2025
01.07.2024 01.07.2025 |
2 years | +22.40% |
03.07.2023 - 01.07.2025
03.07.2023 01.07.2025 |
3 years | +42.72% |
01.07.2022 - 01.07.2025
01.07.2022 01.07.2025 |
5 years | +67.12% |
01.07.2020 - 01.07.2025
01.07.2020 01.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.52% | |
---|---|---|
ASML Holding NV | 2.51% | |
Nestle SA | 2.07% | |
Roche Holding AG | 1.83% | |
Novartis AG Registered Shares | 1.83% | |
Novo Nordisk AS Class B | 1.76% | |
AstraZeneca PLC | 1.73% | |
HSBC Holdings PLC | 1.71% | |
Shell PLC | 1.69% | |
Siemens AG | 1.58% | |
Last data update | 27.06.2025 |
TER | 0.13% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.09% |
Ongoing Charges *** | 0.09% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |